You are here

Daiichi Sankyo

Ranbaxy: FDA Issues Will Take Long Time To Resolve

WSJ Online

Mon, 11/9/09 - 11:26 am

Effient and Onglyza Start Slow—And That May Not Be A Bad Thing

InVivo

Mon, 10/26/09 - 11:58 am

Bristol-Myers Squibb

MorphoSys, Daiichi Sankyo Enter Alliance to Develop Antibodies

Bloomberg

Tue, 10/20/09 - 09:07 am

antibody discovery

Strange Bedfellows: Rival Medical Firms Launch Joint Stent Study

WSJ Online

Fri, 10/2/09 - 10:40 am

Boston Scientific

Abbott Laboratories

Bristol-Myers Squibb

Study: Patients using Effient cost less

Fierce Pharma

Fri, 09/25/09 - 11:56 am

Japan's Daiichi Sankyo says new flu drug effective

Google/AFP

Mon, 08/10/09 - 09:58 am

Daiichi Sankyo Posts First-Quarter Loss on Ranbaxy

Bloomberg

Fri, 07/31/09 - 08:19 am

Is Lilly's Effient Sufficient?

CNBC

Mon, 07/13/09 - 11:48 am

How dangerous is Effient to Plavix?

Fierce Pharma

Mon, 07/13/09 - 11:29 am

Daiichi Sankyo Rises as FDA Approves Anti-Clot Drug

Bloomberg

Mon, 07/13/09 - 08:59 am

Blood Thinner's Approval A Muted Win For Lilly

Forbes

Sat, 07/11/09 - 08:53 am

Daiichi Sankyo Seeks Biotechnology, Cardiovascular Takeovers

Bloomberg

Wed, 06/10/09 - 04:38 am

Daiichi Sankyo Restates Loss on Ranbaxy Stock Slide

WSJ Online

Thu, 05/28/09 - 07:09 am

Daiichi Sankyo Shares Climb After Unit’s Chief Quits

Bloomberg

Tue, 05/26/09 - 08:27 am

Daiichi's Ranbaxy Buy a Harsh Lesson

WSJ Online

Tue, 05/12/09 - 07:34 am

Japan Pharma to hold fire amid mega-M&A deals

Reuters

Tue, 03/17/09 - 09:29 am

Daiichi Sankyo Slumps on U.S. Rejection of Ranbaxy

Bloomberg

Fri, 02/27/09 - 07:59 am

Morning News Roundup 2.26.09

Cafepharma Detailpiece

Thu, 02/26/09 - 08:40 am

Abbott Laboratories

Ranbaxy’s FDA Problems Cause Headaches for Daiichi Sankyo

WSJ Online

Thu, 02/26/09 - 08:02 am

Daiichi Sankyo to launch flu preventive drug-Nikkei

Reuters

Sun, 02/22/09 - 10:37 am

Pages